WASHINGTON - It was the start of something big - really big.
NEW YORK - Making mini satellite dishes that collect signals or building remote-controlled mini Rovers such as the kind NASA has used on Mars are the types of activities that could interest kids in science, but their complexity can derail all but the most enthusiastic hobbyist.
- A University of Utah committee investigating reports that a Salt Lake City fertility clinic worker artificially inseminated a patient with his own sperm called the action "unacceptable" on Thursday, but said it could not determine whether the switch was intentional.
CHICAGO - International teams of researchers using advanced gene sequencing technology have uncovered a single genetic mutation responsible for a rare brain disorder that may have stricken families in Turkey for some 400 years.
WASHINGTON - An international team of scientists has deciphered the genetic code of the tsetse fly, the bloodsucking insect that spreads deadly African sleeping sickness, with the hope that its biological secrets can be exploited to eradicate this malady.
CAPE CANAVERAL, Florida - Two U.S. astronauts floated outside the International Space Station on Wednesday to replace a failed computer that serves as a backup to critical control systems, including the outpost's solar panel wings.
BOWDOINHAM, Maine - The number of baby lobsters in the Gulf of Maine has dropped by half since 2007, a phenomenon that has puzzled scientists as the population of adult lobsters remains near a record high, contributing to robust catches.
CAPE CANAVERAL, Florida - The chance of a city-killing asteroid striking Earth is higher than scientists previously believed, a non-profit group building an asteroid-hunting telescope said on Tuesday.
LONDON - Sun seekers who leave northern Europe for warmer climes are marginally less happy than those left behind, a study found.
WASHINGTON - The first of six U.S. test sites chosen to perform unmanned aircraft systems (UAS) research will start flight operations during the week of May 5, the U.S. Federal Aviation Administration said on Monday.
ZURICH - Patients taking Novartis' inhaled medicine Onbrez Breezhaler for chronic lung disease had benefits similar to those taking GlaxoSmithKline's Seretide, the Swiss drugmaker said on Friday, citing a late stage study.